Document

Exhibit 99.1

Trupanion Reports Fourth Quarter and Full Year 2019 Results

SEATTLE, WA. February 13, 2020 -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and year ended December 31, 2019.

“Over the past two decades, we’ve delivered consistent growth while scaling our operating expenses,” said Darryl Rawlings, Founder and CEO of Trupanion. "The consistency of our growth highlights our recurring revenue, supported by industry leading retention rates, and deep competitive moats. Our moats have taken decades for us to dig and position us to benefit from the growing spotlight on our category.”

2019 Financial and Business Highlights


•	Total revenue was $383.9 million, an increase of 26% compared to 2018.


•	Total enrolled pets (including pets from our other business segment) was 646,728 at December 31, 2019, an increase of 24% over 2018.


•	Subscription business revenue was $321.2 million, an increase of 22% compared to 2018.


•	Subscription enrolled pets was 494,026 at December 31, 2019, an increase of 15% over 2018.


•	Net loss was $(1.8) million, or $(0.05) per basic and diluted share, compared to a net loss of $(0.9) million, or $(0.03) per basic and diluted share, in 2018.


•	Adjusted EBITDA was $10.6 million, compared to adjusted EBITDA of $8.6 million in 2018.


•	Operating cash flow was $16.2 million and free cash flow was $10.8 million in 2019. This compared to operating cash flow of $12.7 million and free cash flow of $8.3 million, which excludes the cash outflow of $52.5 million related to the third quarter 2018 purchase of our headquarters building.

Fourth Quarter 2019 Financial and Business Highlights


•	Total revenue was $105.5 million, an increase of 28% compared to the fourth quarter of 2018.


•	Subscription business revenue was $86.6 million, an increase of 22% compared to the fourth quarter of 2018.


•	Net income was $0.6 million, or $0.02 per basic and diluted share, compared to a net loss of $(0.3) million, or $(0.01) per basic and diluted share, in the fourth quarter of 2018.


•	Adjusted EBITDA was $3.7 million, compared to adjusted EBITDA of $2.5 million in the fourth quarter of 2018.


•	Operating cash flow was $4.5 million and free cash flow was $2.7 million for the fourth quarter of 2019. This compared to operating cash flow of $3.7 million and free cash flow of $2.6 million in the fourth quarter of 2018.

Revenue by Quarter

Conference Call

Trupanion’s management will host a conference call today to review its fourth quarter 2019 results. The call is scheduled to begin shortly after 1:30 p.m. PT/ 4:30 p.m. ET. A live webcast will be accessible through the Investor Relations section of Trupanion’s website at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. Participants can access the conference call by dialing 1-877-407-0784 (United States) or 1-201-689-8560 (International). A telephonic replay of the call will also be available after the completion of the call, by dialing 1-844-512-2921 (United States) or 1-412-317-6671 (International) and entering the replay pin number: 13698321.

About Trupanion

Trupanion is a leader in medical insurance for cats and dogs throughout the United States and Canada. For almost two decades, Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet owners with the highest value in pet medical insurance with unlimited payouts for the life of their pets. Trupanion is listed on NASDAQ under the symbol "TRUP". The company was founded in 2000 and is headquartered in Seattle, WA. Trupanion policies are issued, in the United States, by its wholly-owned insurance entity American Pet Insurance Company and, in Canada, by Omega General Insurance Company. For more information, please visit trupanion.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 relating to, among other things, expectations, plans, prospects and financial results for Trupanion, including, but not limited to, its expectations regarding its ability to execute its business plans. These forward-looking statements are based upon the current expectations and beliefs of Trupanion’s management as of the date of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements made in this press release are based on information available to Trupanion as of the date hereof, and Trupanion has no obligation to update these forward-looking statements.

In particular, the following factors, among others, could cause results to differ materially from those expressed or implied by such forward-looking statements: the ability to achieve or maintain profitability and/or appropriate levels of cash flow in future periods; the ability to keep growing our membership base and revenue; the accuracy of assumptions used in determining appropriate member acquisition expenditures; the severity and frequency of claims; the ability to maintain high retention rates; the accuracy of assumptions used in pricing medical plan subscriptions and the ability to accurately estimate the impact of new products or offerings on claims frequency; actual claims expense exceeding estimates; regulatory and other constraints on the ability to institute, or the decision to otherwise delay, pricing modifications in response to changes in actual or estimated claims expense; the effectiveness and statutory or regulatory compliance of our Territory Partner model and of our Territory Partners, veterinarians and other third parties in recommending medical plan subscriptions to potential members; the ability to retain existing Territory Partners and increase the number of Territory Partners and active hospitals; compliance by us and those referring us members with laws and regulations that apply to our business, including the sale of a pet medical plan; the ability to maintain the security of our data; fluctuations in the Canadian currency exchange rate; the ability to protect our proprietary and member information; the ability to maintain our culture and team; the ability to maintain the requisite amount of risk-based capital; our ability to implement and maintain effective controls, including over financial reporting; the ability to protect and enforce Trupanion’s intellectual property rights; the ability to continue key contractual relationships with third parties; third-party claims including litigation and regulatory actions; the ability to recognize benefits from investments in new solutions and enhancements to Trupanion’s technology platform and website; and our ability to retain key personnel.

For a detailed discussion of these and other cautionary statements, please refer to the risk factors discussed in filings with the Securities and Exchange Commission (SEC), including but not limited to, Trupanion’s Annual Report on Form 10-K for the year ended December 31, 2018 and any subsequently filed reports on Forms 10-Q and 8-K. All documents are available through the SEC’s Electronic Data Gathering Analysis and Retrieval system at www.sec.gov or the Investor Relations section of Trupanion’s website at http://investors.trupanion.com.

Non-GAAP Financial Measures

Trupanion’s stated results include certain non-GAAP financial measures. These non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in its industry as other companies in its industry may calculate or use non-GAAP financial measures differently. In addition, there are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies and exclude expenses that may have a material impact on Trupanion’s reported financial results. The presentation and utilization of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for the directly comparable financial measures prepared in accordance with GAAP. Trupanion urges its investors to review the reconciliation of its non-GAAP financial measures to the most directly comparable GAAP financial measures in its consolidated financial statements, and not to rely on any single financial or operating measure to evaluate its business. These reconciliations are included below and on Trupanion’s Investor Relations website.

Because of varying available valuation methodologies, subjective assumptions and the variety of equity instruments that can impact a company’s non-cash expenses, Trupanion believes that providing various non-GAAP financial measures that exclude stock-based compensation expense and depreciation and amortization expense allows for more meaningful comparisons between its operating results from period to period. Trupanion offsets sales and marketing expense with sign-up fee revenue in the calculation of net acquisition cost because it collects sign-up fee revenue from new members at the time of enrollment and considers it to be an offset to a portion of Trupanion’s sales and marketing expenses. Trupanion believes this allows it to calculate and present financial measures in a consistent manner across periods. Trupanion’s management believes that the non-GAAP financial measures and the related financial measures derived from them are important tools for financial and operational decision-making and for evaluating operating results over different periods of time.

Changes in Presentation of Key Operating Metrics

Trupanion presents various key operating metrics that managements uses to assess the company’s performance. Starting with the year ended December 31, 2019, Trupanion has updated its calculation of lifetime value of a pet (LVP) to include general and administrative and technology expenses, now referred to as lifetime value of a pet, including fixed expenses. This change was made in order to provide a more fulsome metric when calculating the estimated payback period for pet acquisition spend. For further discussion of the key operating metrics Trupanion uses, including a reconciliation between its historical presentation of LVP and its new presentation of lifetime value of a pet, including fixed expenses, please refer to Trupanion’s Annual Report on Form 10-K for the year ended December 31, 2019.



Trupanion, Inc. Consolidated Statements of Operations (in thousands, except share data)
	Three Months Ended December 31,						Year Ended December 31,
	2019			2018			2019			2018
	(unaudited)
Revenue:
Subscription business	$	86,592		$	70,933		$	321,163		$	263,738
Other business	18,891			11,707			62,773			40,218
Total revenue	105,483			82,640			383,936			303,956
Cost of revenue:
Subscription business⁽¹⁾	70,718			57,892			262,139			215,992
Other business	17,031			10,543			56,873			36,598
Total cost of revenue⁽²⁾	87,749			68,435			319,012			252,590
Gross profit:
Subscription business	15,874			13,041			59,024			47,746
Other business	1,860			1,164			5,900			3,620
Total gross profit	17,734			14,205			64,924			51,366
Operating expenses:
Technology and development⁽¹⁾	2,556			2,487			10,074			9,248
General and administrative⁽¹⁾	5,312			4,922			20,967			18,164
Sales and marketing⁽¹⁾	9,212			6,994			35,451			24,999
Total operating expenses	17,080			14,403			66,492			52,411
Gain (loss) from investment in joint venture	(21		)	—			(352		)	—
Operating income (loss)	633			(198		)	(1,920		)	(1,045		)
Interest expense	375			311			1,349			1,198
Other income, net	(535		)	(238		)	(1,629		)	(1,309		)
Loss before income taxes	793			(271		)	(1,640		)	(934		)
Income tax expense (benefit)	157			4			169			(7		)
Net income (loss)	$	636		$	(275	)	$	(1,809	)	$	(927	)

Net income (loss) per share:
Basic	$	0.02		$	(0.01	)	$	(0.05	)	$	(0.03	)
Diluted	0.02			(0.01		)	(0.05		)	(0.03		)
Weighted average common shares outstanding:
Basic	34,876,438			33,716,975			34,645,345			31,961,192
Diluted	36,354,620			33,716,975			34,645,345			31,961,192

⁽¹⁾Includes stock-based compensation expense as follows:	Three Months Ended December 31,						Year Ended December 31,
⁽¹⁾Includes stock-based compensation expense as follows:	Three Months Ended December 31,						Year Ended December 31,
	2019			2018			2019			2018
Cost of revenue	$	267		$	230		$	1,050		$	927
Technology and development	97			42			364			209
General and administrative	860			595			3,312			2,304
Sales and marketing	547			355			2,120			1,335
Total stock-based compensation expense	$	1,771		$	1,222		$	6,846		$	4,775

⁽²⁾The breakout of cost of revenue between veterinary invoice expense and other cost of revenue is as follows:
	Three Months Ended December 31,						Year Ended December 31,
	2019			2018			2019			2018
Veterinary invoice expense	$	74,646		$	58,343		$	270,947		$	214,539
Other cost of revenue	13,103			10,092			48,065			38,051
Total cost of revenue	$	87,749		$	68,435		$	319,012		$	252,590



Trupanion, Inc. Consolidated Balance Sheets (in thousands, except share data)
	December 31, 2019			December 31, 2018

Assets
Current assets:
Cash and cash equivalents	$	29,168		$	26,552
Short-term investments	69,732			54,559
Accounts and other receivables	54,408			31,565
Prepaid expenses and other assets	5,513			5,300
Total current assets	158,821			117,976
Restricted cash	1,400			1,400
Long-term investments, at fair value	4,323			3,554
Property and equipment, net	70,372			69,803
Intangible assets, net	7,731			8,071
Other long-term assets	14,553			6,706
Total assets	$	257,200		$	207,510
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$	4,087		$	2,767
Accrued liabilities and other current liabilities	13,798			11,347
Reserve for veterinary invoices	21,194			16,062
Deferred revenue	52,546			33,027
Total current liabilities	91,625			63,203
Long-term debt	26,086			12,862
Deferred tax liabilities	1,118			1,002
Other liabilities	1,611			1,270
Total liabilities	120,440			78,337
Stockholders’ equity:
Common stock: $0.00001 par value per share, 100,000,000 shares authorized at December 31, 2019 and December 31, 2018, 35,876,882 and 34,947,017 shares issued and outstanding at December 31, 2019; 34,781,121 and 34,025,136 shares issued and outstanding at December 31, 2018	—			—
Preferred stock: $0.00001 par value per share, 10,000,000 shares authorized at December 31, 2019 and December 31, 2018, and 0 shares issued and outstanding at December 31, 2019 and December 31, 2018	—			—
Additional paid-in capital	232,731			219,838
Accumulated other comprehensive loss	250			(753		)
Accumulated deficit	(85,520		)	(83,711		)
Treasury stock, at cost: 929,865 shares at December 31, 2019 and 755,985 shares at December 31, 2018	(10,701		)	(6,201		)
Total stockholders’ equity	136,760			129,173
Total liabilities and stockholders’ equity	$	257,200		$	207,510



Trupanion, Inc. Consolidated Statements of Cash Flows (in thousands)
	Three Months Ended December 31,						Year Ended December 31,
	2019			2018			2019			2018
	(unaudited)
Operating activities
Net income (loss)	$	636		$	(275	)	$	(1,809	)	$	(927	)
Adjustments to reconcile net loss to cash provided by operating activities:
Depreciation and amortization	1,274			1,486			5,632			4,512
Stock-based compensation expense	1,771			1,222			6,846			4,775
Gain on sale of equity method investment	—			—			—			—
Other, net	(38		)	(5		)	105			(240		)
Changes in operating assets and liabilities:
Accounts and other receivables	(4,190		)	344			(22,772		)	(11,248		)
Prepaid expenses and other assets	(707		)	(2,079		)	(432		)	(2,628		)
Accounts payable, accrued liabilities, and other liabilities	1,304			682			4,110			4,531
Reserve for veterinary invoices	1,872			1,956			5,059			3,440
Deferred revenue	2,610			332			19,418			10,465
Net cash provided by operating activities	4,532			3,663			16,157			12,680
Investing activities
Purchases of investment securities	(20,014		)	(23,295		)	(65,506		)	(52,862		)
Maturities of investment securities	21,538			8,008			49,762			35,413
Purchases of other investments	(4,000		)	—			(4,000		)	(3,000		)
Acquisition of lease intangibles, related to corporate real estate acquisition	—			—			—			(2,959		)
Purchases of property and equipment	(1,787		)	(1,080		)	(5,373		)	(56,936		)
Other	(954		)	(255		)	(2,891		)	(1,107		)
Net cash used in investing activities	(5,217		)	(16,622		)	(28,008		)	(81,451		)
Financing activities
Proceeds from public offering of common stock, net of offering costs	—			—			—			65,671
Proceeds from exercise of stock options	727			729			2,982			3,601
Shares withheld to satisfy tax withholding	(57		)	—			(1,667		)	(1,839		)
Proceeds from debt financing, net of financing fees	4,000			4,242			13,167			13,431
Repayment of debt financing	—			—			—			(10,000		)
Other financing	—			581			(438		)	365
Net cash provided by financing activities	4,670			5,552			14,044			71,229
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash, net	156			(718		)	423			(812		)
Net change in cash, cash equivalents, and restricted cash	4,141			(8,125		)	2,616			1,646
Cash, cash equivalents, and restricted cash at beginning of period	26,427			36,077			27,952			26,306
Cash, cash equivalents, and restricted cash at end of period	$	30,568		$	27,952		$	30,568		$	27,952



The following tables set forth our key operating metrics:

	Year Ended December 31,

	2019			2018
Total Business:
Total pets enrolled (at period end)	646,728			521,326
Subscription Business:
Total subscription pets enrolled (at period end)	494,026			430,770
Monthly average revenue per pet	$	57.52		$	54.34
Lifetime value of a pet, including fixed expenses	$	523		$	449
Average pet acquisition cost (PAC)	$	212		$	164
Average monthly retention	98.58		%	98.60		%


	Three Months Ended
	Dec. 31, 2019			Sept. 30, 2019			Jun. 30, 2019			Mar. 31, 2019			Dec. 31, 2018			Sept. 30, 2018			Jun. 30, 2018			Mar. 31, 2018
Total Business:
Total pets enrolled (at period end)	646,728			613,694			577,686			548,002			521,326			497,942			472,480			446,533
Subscription Business:
Total subscription pets enrolled (at period end)	494,026			479,427			461,314			445,148			430,770			416,527			401,033			385,640
Monthly average revenue per pet	$	58.58		$	58.12		$	57.11		$	56.13		$	55.15		$	54.55		$	53.96		$	53.62
Lifetime value of a pet, including fixed expenses	$	523		$	511		$	482		$	471		$	449		$	435		$	431		$	419
Average pet acquisition cost (PAC)	$	222		$	208		$	213		$	205		$	186		$	155		$	150		$	165
Average monthly retention	98.58		%	98.59		%	98.57		%	98.58		%	98.60		%	98.61		%	98.64		%	98.63		%



The following table reflects the reconciliation of cash provided by operating activities to free cash flow (in thousands):

	Three Months Ended December 31,						Year Ended December 31,
	2019			2018			2019			2018
Net cash provided by operating activities	$	4,532		$	3,663		$	16,157		$	12,680
Purchases of property and equipment	(1,787		)	(1,080		)	(5,373		)	(56,936		)
Free cash flow	$	2,745		$	2,583		$	10,784		$	(44,256	)
Exclude building purchase, net of acquired lease intangibles	—			—			—			52,534
Free cash flow, excluding building purchase, net of acquired lease intangibles	$	2,745		$	2,583		$	10,784		$	8,278



The following tables reflect the reconciliation of acquisition cost and net acquisition cost to sales and marketing expense (in thousands):

	Year Ended December 31,

	2019			2018
Sales and marketing expenses	$	35,451		$	24,999
Excluding:
Stock-based compensation expense	(2,120		)	(1,335		)
Acquisition cost	33,331			23,664
Net of:
Sign-up fee revenue	(2,957		)	(2,587		)
Other business segment sales and marketing expense	(414		)	(377		)
Net acquisition cost	$	29,960		$	20,700

	Three Months Ended
	Dec. 31, 2019			Sept. 30, 2019			Jun. 30, 2019			Mar. 31, 2019			Dec. 31, 2018			Sept. 30, 2018			Jun. 30, 2018			Mar. 31, 2018
Sales and marketing expenses	$	9,212		$	9,255		$	8,757		$	8,227		$	6,994		$	6,365		$	5,702		$	5,938
Excluding:
Stock-based compensation expense	(547		)	(577		)	(567		)	(429		)	(355		)	(358		)	(349		)	(273		)
Acquisition cost	8,665			8,678			8,190			7,798			6,639			6,007			5,353			5,665
Net of:
Sign-up fee revenue	(730		)	(790		)	(734		)	(703		)	(655		)	(693		)	(624		)	(616		)
Other business segment sales and marketing expense	(152		)	(94		)	(38		)	(130		)	(102		)	(99		)	(88		)	(87		)
Net acquisition cost	$	7,783		$	7,794		$	7,418		$	6,965		$	5,882		$	5,215		$	4,641		$	4,962



The following tables reflect the reconciliation of adjusted EBITDA to net income (loss) (in thousands):

	Year Ended December 31,

	2019			2018
Net loss	$	(1,809	)	$	(927	)
Excluding:
Stock-based compensation expense	6,846			4,775
Depreciation and amortization expense	5,632			4,512
Interest income	(1,681		)	(862		)
Interest expense	1,349			1,198
Other non-operating expenses	201			—
Income tax expense (benefit)	169			(7		)
Gain from equity method investment	(125		)	(107		)
Adjusted EBITDA	$	10,582		$	8,582

	Three Months Ended
	Dec. 31, 2019			Sept. 30, 2019			Jun. 30, 2019			Mar. 31, 2019			Dec. 31, 2018			Sept. 30, 2018			Jun. 30, 2018			Mar. 31, 2018
Net income (loss)	$	636		$	782		$	(1,931	)	$	(1,296	)	$	(275	)	$	1,205		$	(377	)	$	(1,480	)
Excluding:
Stock-based compensation expense	1,771			1,845			1,873			1,357			1,222			1,299			1,286			968
Depreciation and amortization expense	1,274			1,181			1,564			1,613			1,485			1,136			964			927
Interest income	(516		)	(411		)	(412		)	(342		)	(234		)	(317		)	(179		)	(132		)
Interest expense	375			340			317			317			311			336			332			219
Other non-operating expenses	(22		)	122			101			—			—			—			—			—
Income tax expense (benefit)	157			18			(46		)	40			4			(7		)	91			(95		)
(Gain) loss from equity method investment	—			—			(125		)	—			—			—			(107		)	—
Adjusted EBITDA	$	3,675		$	3,877		$	1,341		$	1,689		$	2,513		$	3,652		$	2,010		$	407

Contacts:

Investors:

Laura Bainbridge, Head of Investor Relations

206.607.1929

[email protected]




Delaware	001-36537	83-0480694
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)



Title of each class	Trading Symbol	Name of each exchange on which registered
Common stock, $0.00001 par value per share	TRUP	The NASDAQ Stock Market LLC



(d)	Exhibits

	Exhibit No.	Description
	Exhibit 99.1	Press release issued by Trupanion, Inc. dated February 13, 2020
	104	Cover Page Interactive Data File (formatted as Inline XBRL)




TRUPANION, INC.

By:	/s/ Tricia Plouf
	Name: Tricia Plouf
	Title: Chief Financial Officer



☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)



☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)



☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))